Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
3 hedge funds and large institutions have $11.2M invested in Motif Bio plc ADRs in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $12M → $11.2M (-$754K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$576K |
| 2 |
Jane Street
New York
|
-$79K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$313 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $6.61M | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $4.6M | -$576K | -91,951 | -11% |
|
|
3
Jane Street
New York
| – | -$79K | -12,779 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$14K | -2,309 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$313 | -50 | -50% |
|
MTFB Hedge Fund Activity: Q1 2017 in Review
3 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q1 2017, worth a combined $11.2M — down 6.3% from $12M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MTFB and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, cutting an estimated $576K.
- 3 institutional investors held Motif Bio plc ADRs (MTFB) as of Q1 2017, down from 5 in Q4 2016.
- Funds reported $11.2M of Motif Bio plc ADRs stock for Q1 2017, down 6.3% quarter-over-quarter.
- 0 funds opened new Motif Bio plc ADRs positions in Q1 2017 and 2 closed out, a net change of -2 holders.
- The largest Motif Bio plc ADRs seller in Q1 2017 was Sabby Management, an estimated $576K sold.
Based on aggregated 13F filings for Q1 2017.